Standard Biotools (LAB) EBIT Growth (1y) (2011 - 2026)
Standard Biotools (LAB) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 129.56 Bn | 126.09 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 119.95 Bn | 110.73 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 73.85 Bn | 73.31 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 52.69 Bn | 48.44 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.55 Bn | 32.60 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 34.11 Bn | 32.00 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.22 Bn | 22.73 Bn | 684.20 Mn | 16.18% |
| 10 | Standard Biotools | 256.97 Mn | -219.75 Mn | 10.54 Mn | 1.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20% |
| Mar 31, 2026 | 53.67% |
| Dec 31, 2025 | 5.51% |
| Sep 30, 2025 | -23.37% |
| Jun 30, 2025 | 15.08% |
| Mar 31, 2025 | 55.19% |
| Dec 31, 2024 | -21.96% |
| Sep 30, 2024 | -26.11% |
| Jun 30, 2024 | -73.43% |
| Mar 31, 2024 | -262.70% |
| Dec 31, 2023 | -1.30% |
| Sep 30, 2023 | 27.06% |
| Jun 30, 2023 | 54.75% |
| Mar 31, 2023 | 39.67% |
| Sep 30, 2022 | 48.35% |
| Jun 30, 2022 | -5.40% |
| Mar 31, 2022 | -42.36% |
| Sep 30, 2021 | -928.55% |
| Jun 30, 2021 | -166.56% |
| Mar 31, 2021 | -29.30% |